Nova Leap Health Corp. announced a non-brokered private placement of up to 7,142,857 common shares at a price of CAD 0.35 per share for gross proceeds of up to CAD 2,499,999.95 on August 23, 2022. The transaction may include participation from insiders of the company who are expected to subscribe for up to CAD 1,960,000.

The company may pay a cash finders' fee of up to 6% of the gross proceeds. The insiders are expected to subscribe for up to CAD 1,960,000 of the offering. In connection with the Offering, the company may pay a cash finder's fee of up to 6% of any non-insider proceeds raised from the offering.

The closing of the offering is expected to occur on or about September 2, 2022. The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the TSX Venture Exchange. The common shares issued pursuant to the offering will be subject to a four month hold period in accordance with applicable Canadian securities laws.